The Benzo Killer - FIJ ($25M MC) ($75M ST Target), page-803

In the investors eyes the Amazon agreement isn't an entry to the US - are more so awaiting a major distribution agreement into the US, whether via retail (wholefoods etc) or wholesale (like our $3.5M PathWay agreement for Aus for raw Kava ingredients/b2b)

Keeping in mind that the US is Kavas biggest international market, and AUS being relatively small, that $3.5M Aus contract and the $8M chinese contract as reference points as to what these sizeable contracts look like in other markets, I'm expecting a $5-15M if it's an exclusive wholesale/pharmaceutical US contract, alongside distribution deals such as wholefoods.

That really is the big one, the US market. Or alternatively it's a many smaller contracts if not exclusive.